Legislation, policies and organization of community based centers for HIV diagnosis and prevention in Piedmont Region.
Author(s)
Valerio Brescia , Vania Tradori , Paolo Pietro Biancone , Silvana Secinaro ,
Download Full PDF Pages: 17-27 | Views: 1416 | Downloads: 380 | DOI: 10.5281/zenodo.3473817
Abstract
The article describes how the fight against AIDS is tackled, from an organizational and legislative point of view, especially with regard to HIV test offer to as many people as possible, with a focus on people with higher at-risk behaviors, in order to reduce the cases of immunodeficiency and unawareness of the serological state. The community-based services and the implementing policies of Piedmont Region answer to the need for integration already offered by the Regional Health Service. The features and results confirmed by a pilot project can be a useful reference for the activation of integrated services on the territory.
Keywords
HIV, community-based, legislation, and organization of diagnosis centers.
References
Articles on magazines
i. Smith MK, Rutstein SE, Powers KA, Fidler S, Miller WC, Eron JJ Jr, Cohen MS. The detection and management of early HIV infection: a clinical and public health emergency. J Acquir Immune Defic Syndr.2013; 63 Suppl 2:S187-99
ii. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493–505.
iii. Rietmeijer CA , Kane MS, Simons PZ, et al. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program. AIDS 1996;10:291–8.
iv. Rhodes F, Malotte CK. HIV risk interventions for active drug users. In: S.Oskamp, S.Thompson, eds. Understanding HIV risk behavior: safer sex and drug use. Thousand Oaks, CA: Sage Publications, 1996:297–36.
v. Gibson DR, Lovelle-Drache J, Young M, Hudes ES, Sorensen JL. Effectiveness of brief counseling in reducing HIV risk behavior in injecting drug users: final results of randomized trials of counseling with and without HIV testing. AIDS and Behavior 1999;3:3–12.
vi. Doll LS, O'Malley PM, Pershing AL, Darrow WW, Hessol NA, Lifson AR. High-risk sexual behavior and knowledge of HIV antibody status in the San Francisco City Clinic Cohort. Health Psychol 1990;9:253–65.
vii. Cleary PD, Van Devanter N, Rogers TF, et al. Behavior changes after notification of HIV infection. Am J Pub Health 1991;81:1586–90.
viii. Fox R, Odaka NJ, Brookmeyer R, Polk BF. Effect of HIV antibody disclosure on subsequent sexual activity in homosexual men. AIDS 1987;1:241–6.
ix. Van Griensven GJP, de Vroome EMM, Tielman RAP, et al. Effect of human immunodeficiency virus (HIV) antibody knowledge on high-risk sexual behavior with steady and nonsteady sexual partners among homosexual men. Am J Epidemiol 1989;129:596–603.
x. Coates TJ, Morin SF, McKusick L. Behavioral consequences of AIDS antibody testing among gay men [Letter]. JAMA 1987;258:1889.
xi. Wenger NS, Kusseling FS, Beck K, Shapiro MF. Sexual behavior of individuals infected with the human immunodeficiency virus: the need for intervention. Arch Intern Med 1994;154:1849–54.
xii. Desenclos J-C, Papaevangelou G, Ancelle-Park R, for the European Community Study Group on HIV in Injecting Drug Users. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. AIDS 1993;7:1371–7.
xiii. Dawson J, Fitzpatrick R, McLean J, Hart G, Boulton M. The HIV test and sexual behavior in a sample of homosexually active men. Soc Sci Med 1991;32:683–8.
xiv. Otten MW Jr, Zaidi AA, Wroten JE, Witte J, Peterman TA. Changes in sexually transmitted disease rates after HIV testing and posttest counseling, Miami, 1988 to 1989. Am J Pub Health 1993;83:529–33.
xv. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Eng J Med 2000;342:921–9.
xvi. 18 CDC. Cases of HIV infection and AIDS in the United States, 2004. HIV/AIDS Surveillance Report 2005;16:16-45.
xvii. Tao G, Irwin KL, Kassler WJ. Missed opportunities to assess STDs in US adults during routine medical checkups. Am J Prev Med 2000;18:109–14.
xviii. CDC. HIV prevention practices of primary care physicians—United States, 1992. MMWR 1994;42:988–92.
xix. Tiara DA, Safran DG, Seto TB, Rogers WH, Tarlov AR. The relationship between patient income and physician discussion of health risk behaviors. JAMA 1997;278:1412–7.
xx. Schwartz JS, Lewis CE, Clancy C, Kinosian MS, Radany MH, Koplan JP. Internists' practices in health promotion and disease prevention. Ann Intern Med 1991;114:46–53.
xxi. Kassler WJ, Dillon GA, Haley C, et at. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045–51.
xxii. Horton T, Uniyal A, Smith LV, Curreri S, Kerndt P, Branson B. Feasibility of implementing rapid HIV testing in a community-based setting. National HIV Prevention Conference; Atlanta GA; July 2003. Abstract T2-C1503.
xxiii. Luo W, Masciotra S, Delaney KP, Charurat M, Croxton T, Constantine N, et al. Comparison of HIV oral fluid and plasma antibody results during early infection in a longitudinal Nigerian cohort. J Clin Virol, 2013. 58 Suppl 1: e113-8.
xxiv. Masciotra S, Luo W, Youngpairoj AS, Kennedy MS, Wells S, Ambrose K, et al. Performance of the Alere Determine HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-1 seroconverters from the US and HIV-2 infected individuals from Ivory Coast. J Clin Virol, 2013.
xxv. Bert, F., Gualano, M. R., Biancone, P., Brescia, V., Camussi, E., Martorana, M., ... & Siliquini, R. (2016). HIV-screening in pregnant women: a systematic review of cost-effectiveness studies: Fabrizio Bert. The European Journal of Public Health, 26(suppl_1), ckw174-023.
xxvi. Girardi, E., Sabin, C. A., & Antonella d'Arminio Monforte, M. D. (2007). Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46, S3-S8.
xxvii. Raimondo, M., Pasqualini, C., Ghisetti, V., Regine, V., Camoni, L., Salfa, M. C., & Suligoi, B. (2010). Recent HIV infection among newly diagnosed with HIV cases in Turin, Italy. Retrovirology, 7(1), P98.
xxviii. Camoni, L., Pasqualini, C., Regine, V., D’Amato, S., Raimondo, M., Pompa, M. G., ... & Suligoi, B. (2012). An improved data-collection form for the surveillance of HIV infection in Italy. Italian Journal of Public Health, 7(1).
xxix. Blystad H, Wiessing L. Guidance on Provider-initiated Voluntary Medical Examination, Testing and Counselling for Infectious Diseases in Injecting Drug Users. Pre-final unedited version 5.5. EMCDDA. Lisbon: 2009.
xxx. Leaity S, Sherr L, Wells H, Evans A, Miller R, Johnson M, et al. Repeat HIV testing: high-risk behaviour or risk reduction strategy? AIDS 2000;14(5):547-52.
xxxi. Fernyak SE, Page-Shafer K, Kellogg TA, McFarland W, Katz MH. Risk behaviors and HIV incidence among repeat testers at publicly funded HIV testing sites in San Francisco. J Acquir Immune Defic Syndr. 2002;31(1):63-70.
xxxii. Hightow LB, Miller WC, Leone PA, Wohl DA, Smurzynski M, Kaplan AH. Predictors of repeat testing and HIV seroconversion in a sexually transmitted disease clinic population. Sex Transm Dis. 2004;31(8):455-9.
xxxiii. MacKellar DA, Valleroy LA, Secura GM, Bartholow BN, McFarland W, Shehan D, et al. Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: a call to monitor and improve the practice of prevention. J Acquir Immune Defic Syndr. 2002;29(1):76-85.
xxxiv. N.Lorente et All., Expanding Access to Non-Medicalized Community-Based Rapid Testing to Men Who Have Sex with Men: An Urgent HIV Prevention Intervention (The ANRS-DRAG Study), Plos One April 2013 vol.8 issue 4.
xxxv. M. Meulbroeck et All, BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care, British HIV Association, HIV Medicine 2013, supl. 3 25-28.
xxxvi. Tavs Quist et All., High Linkage to Care in a Community-Based Rapid HIV Testing and Counseling Project Among Men Who Have Sex With Men in Copenhagen, Sexually Transmitted Diseases & Volume 41, Number 3, March 2014.
xxxvii. A.D.Castel et All, Comparing Cost-Effectiveness of HIV Testing Strategies: Targeted and Routine Testing in Washington, DC, PLOS ONE | DOI:10.1371/journal.pone.0139605 October 14, 2015.
Acts and publications of Public Bodies
i. CDC, Rapid HIV tests suitable for use in non-clinical settings (CLIA-waived), updates 11/07/2016
ii. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 U.S. dependent areas—2011. HIV Surveillance Supplemental Report 2013;18(No. 5). Published October 2013.
iii. CDC. Estimated HIV incidence in the United States, 2007–2010. HIV Surveillance Supplemental Report 2012;17(No. 4). Published December 2012.
iv. SEREMI, HIV and AIDS in Piedmont. Update 2014 (ed. 2015), November 2015.
v. REGIONAL PLAN FOR PREVENTION 2014-2018. Approval of prevention programmes for the period 2015-2018 "; Piedmont Region.
vi. Consent Document on offer policies and test execution’s modes of the HIV Test in Italy "; Ministry of Health, National AIDS Commission, year 2011.
vii. Ministry of Health, IRCCS Spallanzani of Rome, rapid test Offer in unconventional contexts, November 30, 2015.
viii. WHO, Consolidated guidelines on HIV testing services, July 2015.
ix. ECDC GUIDANCE. HIV testing: increasing uptake and effectiveness in the European Union. December 2010
x. ECDC Guidance: Prevention and control of infectious diseases among people who inject drugs (2011)
xi. ECDC TECHNICAL REPORT Assessing the burden of key infectious diseases affecting migrant populations in the EU/EEA. May 2014.
xii. HIV/AIDS Epi Update — Chapter 13: HIV/AIDS in Canada among people from countries where HIV is endemic Centre for Communicable Diseases and Infection Control Public Health Agency of Canada http://www.phac-aspc.gc.ca/aids-sida/publication/epi/2010/chap13-eng.php
xiii. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. October 2012. https://issuu.com/kandrup/docs/chip_guidance?e=4233206/1998749
xiv. HIV testing in Europe. Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia. Progress report. February 2004.
xv. POLICY BRIEF: WHO RECOMMENDS HIV TESTING BY LAY PROVIDERS, World Health Organization, July 2015
xvi. SEREMI HIV TEST OFFER POLICIES IN PIEDMONT 2016", developed by the Piedmonte Health Department, year 2016.
Books
i. Management of Health and Territorial Services, efficiency and social valorisation, Publiedit Editions, 2017 ISBN: 978-88-95425-09-2
Legislation
i. HIV Test Offer in Piedmont, Piedmont Regional Health Direction, prot. 24314A1409A of November 30, 2016.
ii. Consent to HIV test by the child. Annex DD 564 of October 1, 2009 Piedmont Region.
iii. DGR 25 - 4082 of July 2, 2012. Transposition of the Agreement approved by the State-Regions Conference on “Consent Document on offer policies and test execution’s modes of the HIV Test” Piedmont Region.
iv. Consent Document on offer policies and test execution’s modes of the HIV Test. Ministry of Health (GU General Series n.191 of 18-8-2011) Piedmont Region.
v. DECISION OF THE PRESIDENT OF THE COUNCIL OF MINISTERS of January 12, 2017; President of the Council of Ministers: Gentiloni Silveri, Minister of Health: Lorenzin, Minister of Economy and Finance: Padoan; January 12, 2017.
Cite this Article: